Minnesota Oncology/Hematology Associates of Central Illinois — Minneapolis, Minnesota

Minnesota Oncology/Hematology Associates of Central Illinois is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Minnesota Oncology/Hematology Associates of Central Illinois has participated in 1 clinical trials.

Therapeutic areas: Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology/Hematology Associates of Central Illinois?

Minnesota Oncology/Hematology Associates of Central Illinois has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology/Hematology Associates of Central Illinois conducted?

Minnesota Oncology/Hematology Associates of Central Illinois has 1 clinical trials on record. Their work covers Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms.

Is Minnesota Oncology/Hematology Associates of Central Illinois accredited by Crixeo Health?

Minnesota Oncology/Hematology Associates of Central Illinois has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology/Hematology Associates of Central Illinois?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.